Post COVID-19 neuropsychiatric complications and therapeutic role for TNF- α inhibitors: a case series study

ConclusionsTo our knowledge, this report is the first case series study that suggests TNF inhibitors in the treatment of post-COVID-19 syndrome, especially neuropsychological complications. However, future studies should evaluate the best therapeutic options for this syndrome.

http://link.springer.com/10.1007/s40200-022-01138-5

Source: Journal of Diabetes and Metabolic Disorders - October 15, 2022 Category: Endocrinology Source Type: research